Stockscreener 앱 받기
1.02
1.92%
-0.02
시간 외 거래:
1.03
0.01
+0.98%
전일 마감가:
$1.04
열려 있는:
$1.04
하루 거래량:
96,613
Relative Volume:
1.25
시가총액:
$55.12M
수익:
$20.59M
순이익/손실:
$24.31M
주가수익비율:
-1.0851
EPS:
-0.94
순현금흐름:
$-44.02M
1주 성능:
-10.53%
1개월 성능:
-11.30%
6개월 성능:
-6.42%
1년 성능:
-21.54%
1일 변동 폭
$1.02
$1.06
1주일 범위
$1.02
$1.16
52주 변동 폭
$0.9901
$1.50
Enzo Biochem Inc Stock (ENZ) Company Profile
명칭
Enzo Biochem Inc
전화
(516) 755-5500
주소
60 EXECUTIVE BLVD, FARMINGDALE, NY
ENZ을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| ENZ | 1.02 | 55.12M | 20.59M | 24.31M | -44.02M | -0.94 |
| TMO | 501.29 | 192.46B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 230.06 | 166.23B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 126.92 | 36.47B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 191.04 | 34.67B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 419.83 | 34.38B | 3.84B | 866.24M | 792.60M | 9.80 |
Enzo Biochem Inc Stock (ENZ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2011-10-18 | 재확인 | Rodman & Renshaw | Mkt Outperform |
| 2009-09-23 | 개시 | Rodman & Renshaw | Mkt Outperform |
| 2007-09-13 | 개시 | Lazard Capital | Buy |
Enzo Biochem Inc 주식(ENZ)의 최신 뉴스
Enzo Biochem (NYSE:ENZ) Now Covered by StockNews.com - MarketBeat
Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com - MarketBeat
We're Keeping An Eye On Enzo Biochem's (NYSE:ENZ) Cash Burn Rate - Yahoo Finance
Enzo Biochem Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.51 loss in FY 2023) - Yahoo Finance UK
ENZ Stock Up Following FY24 Earnings Uptick, Gross Margin Expands - MSN
Enzo Biochem Reports Revenue Growth Despite Losses - TipRanks
Enzo Biochem (NYSE:ENZ) Shares Pass Above 200 Day Moving AverageShould You Sell? - MarketBeat
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend - The Manila Times
Enzo Biochem, Inc. Reports Earnings Results for the Full Year Ended July 31, 2024 - Marketscreener.com
Short Interest in Enzo Biochem, Inc. (NYSE:ENZ) Grows By 8.2% - MarketBeat
Biotech company settles for $4.5M after cybercriminals use decade-old password in massive data breach: NY AG - MSN
Difficult-to-Express Proteins Global Market Report 2024: Forecast And Share 2033 - WhaTech
Multiplex PCR Assays Market Forecast 2024: Innovations, Demand Drivers, and Emerging Technologies - WhaTech
Enzo Biochem (NYSE:ENZ) Coverage Initiated at StockNews.com - MarketBeat
Enzo Biochem (NYSE:ENZ) Stock Price Crosses Above Two Hundred Day Moving Average of $1.13 - MarketBeat
Enzo Biochem (NYSE:ENZ) Research Coverage Started at StockNews.com - MarketBeat
New York City Mayor Eric Adams Charged for Accepting Foreign Bribes - The National Law Review
Recombinant Proteins Market Size to Reach USD 5.0 Billion by 2032, at a CAGR of 7.6%SNS Insider - GlobeNewswire
Bio Lab Settles Conn. False-Claims Allegations For $1.73M - Law360
$1.7 Million Settlement Reached With Clinical Lab - Law.com
Connecticut Attorney General announces $1.7 million false claims settlement with Enzo Clinical Labs - MSN
Canada Pension Plan Investment Board Lowers Stock Position in Edwards Lifesciences Co. (NYSE:EW) - Defense World
First Eagle Investment Management LLC Boosts Holdings in Entegris, Inc. (NASDAQ:ENTG) - Defense World
Canada Pension Plan Investment Board Boosts Stake in Extra Space Storage Inc. (NYSE:EXR) - Defense World
Envestnet Asset Management Inc. Purchases 45,253 Shares of Extra Space Storage Inc. (NYSE:EXR) - Defense World
Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
Granite Investment Partners LLC Lowers Holdings in Enovis Co. (NYSE:ENOV) - Defense World
Acadian Asset Management LLC Makes New $276,000 Investment in Entegris, Inc. (NASDAQ:ENTG) - Defense World
Enzo Biochem (NYSE:ENZ) Stock Passes Above 200-Day Moving Average of $1.14 - MarketBeat
AI is Redefining the Hepatitis B and C Diagnostics Market, Set to Grow by USD 3.02 Billion from 2024-2028 with Rising Demand for Molecular DiagnosticsTechnavio - The Malaysian Reserve
AI Is Redefining The Hepatitis B And C Diagnostics Market, Set To Grow By USD 3.02 Billion From 2024-2028 With Rising Demand For Molecular Diagnostics... - MENAFN.COM
Professional Diagnostics Market Giants Spending Is Going To Boom| Becton Dickinson (BD) , Enzo Biochem Inc - Newstrail
Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge - MarketBeat
Extra Space Storage Inc (NYSE:EXR) Raised By Jefferies - FXDailyReport.com
Ensysce Biosciences Submits Phase 3 Protocol to the FDA - StockTitan
India News | ⚡Kolkata-Based Company Ellenbarrie Industrial Gases Files IPO Papers - LatestLY
Immunoassay Market Trends, Outlook, Insights, Overview 2024-2033 - WhaTech
United States Pepsin Inhibitor Market By Application - Third Eye News
ENGAGE XR Posts Revenue Growth and Strategic Deals - TipRanks
Immunoassay Market Projected Growth Outlined by Insights, Competitive Analysis, Latest Trends, And Forecast... - WhaTech
In Vitro Toxicology Market Expansion: Key Research, Trends, and Strategies Powering Growth to $17.1 Billion - WhaTech
Bulgarian Academy of Sciences Issues Report on Results of Its In Vivo Testing of IPF as an Immunomodulator - AccessWire
Extra Storage rises on Jefferies upgrade - XM
Global Immunoassay Market Forthcoming Trends and Share Analysis by 2032 - 대구포스트
Cancer Profiling Market Growth Analysis, Industry Forecast To 2033 - WhaTech
Cardiac Biomarkers Testing Market Strategies to Increase Productivity by 2033 - Cauverynews
End Stage Renal Disease (ESRD) Drug Global Market Innovations Investigated by Size, Growth Demands, Forecas... - WhaTech
Cardiac Biomarkers Testing Global Market Innovations Investigated by Industry Growth and Market Dynamics - WhaTech
Northland Capital’s latest rating for EGIO stock - Knox Daily
Forsta AP Fonden Sells 1,400 Shares of Entegris, Inc. (NASDAQ:ENTG) - Defense World
Federated Hermes Inc. Purchases 4,520 Shares of Entegris, Inc. (NASDAQ:ENTG) - MarketBeat
Enzo Biochem Inc (ENZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.04%
3.19%
자본화:
|
볼륨(24시간):